B. Le

Targeting the Undruggable: Deep Learning-Driven Design of Peptide Therapeutics in Cancer

How advances in artificial intelligence and computational modeling may reshape the rational design of next-generation peptide therapeutics is explored and an integrated experimental–computational framework is proposed to facilitate the development of clinically actionable candidates is proposed.